LECRK3 Antibody

What is LECRK3 and what role does it play in plant immunity?

LECRK3 (Lectin Receptor Kinase 3) belongs to the L-type lectin receptor kinase family in plants, particularly in rice (Oryza sativa). This protein family contains an extracellular lectin domain for carbohydrate binding, a transmembrane region, and a kinase domain . LecRKs play crucial roles in plant immunity by functioning as pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs) .

Research indicates that LecRKs have plasma membrane localization and are involved in signal transduction pathways, serving as receptors for external ligands and transducing these signals into intracellular responses. In rice, these proteins contribute to resistance against various pathogens and pests, including brown planthopper (Nilaparvata lugens) .

What applications are LECRK3 antibodies used for in plant research?

LECRK3 antibodies are primarily used in the following applications:

• Western Blotting (WB): To detect and quantify LECRK3 protein expression in plant tissues

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative analysis of LECRK3 levels

• Immunofluorescence (IF): To study subcellular localization of LECRK3

• Immunoprecipitation (IP): To isolate LECRK3 and its interacting proteins

• Chromatin Immunoprecipitation (ChIP): To study protein-DNA interactions involving LECRK3

These applications allow researchers to study the expression, localization, and function of LECRK3 in plant immunity and development.

What are the key specifications for a typical LECRK3 antibody?

The standard specifications for a research-grade LECRK3 antibody typically include:

These specifications may vary between manufacturers and specific antibody products .

How should LECRK3 antibodies be validated before use in experimental work?

A comprehensive validation strategy for LECRK3 antibodies should include:

• Target specificity validation:

  • Use of knockout/knockdown lines where LECRK3 is absent

  • Competitive binding assays with purified LECRK3 protein

  • Peptide blocking experiments

• Application-specific validation:

  • For Western blot: Confirm single band of expected molecular weight

  • For IF: Verify subcellular localization pattern matches known distribution

  • For ELISA: Establish standard curve with purified protein

• Cross-reactivity assessment:

  • Test against closely related LecRK family members

  • Evaluate in species beyond the primary target organism

• Reproducibility testing:

  • Multiple antibody lots

  • Multiple biological replicates

  • Different laboratory conditions

The gold standard for antibody validation involves using CRISPR-Cas9 engineered knockout cell lines to confirm specificity, as demonstrated in various antibody validation studies . Without proper validation, there is risk of misinterpretation of results, as estimated 50% of commercial antibodies may not meet basic standards for characterization .

What are the optimal tissue extraction protocols for LECRK3 detection in rice samples?

For optimal extraction of LECRK3 from rice tissues:

• Sample collection and preparation:

  • Harvest fresh tissue (preferably leaves, as LECRK expression is often higher in leaves than roots)

  • Flash-freeze in liquid nitrogen and store at -80°C

  • Grind tissue to fine powder in liquid nitrogen using mortar and pestle

• Protein extraction buffer composition:

  • 50 mM Tris-HCl, pH 7.5

  • 150 mM NaCl

  • 1% Triton X-100 or 0.5% NP-40

  • 5 mM EDTA

  • 1 mM DTT

  • Protease inhibitor cocktail (freshly added)

  • Phosphatase inhibitors (important as LecRKs undergo phosphorylation)

• Extraction procedure:

  • Add cold extraction buffer to powdered tissue (ratio: 3-5 ml/g tissue)

  • Vortex and incubate with gentle agitation at 4°C for 30 min

  • Centrifuge at 15,000 × g at 4°C for 15 min

  • Collect supernatant

  • Optional: Second clarification spin at 20,000 × g for 10 min

• Protein quantification:

  • Bradford assay recommended (less interference from buffer components)

  • Standardize all samples to equal protein concentration

For membrane-associated proteins like LECRK3, inclusion of membrane solubilization steps may improve yields, as LecRKs are typically localized to the plasma membrane .

How can Western blot protocols be optimized for LECRK3 antibody detection?

For optimized Western blot detection of LECRK3:

• Sample preparation:

  • Use fresh extracts whenever possible

  • Add 4× Laemmli buffer (with 5% β-mercaptoethanol)

  • Heat at 95°C for 5 minutes (membrane proteins may require only 70°C)

  • Load 20-50 μg total protein per lane

• Gel electrophoresis parameters:

  • 8-10% SDS-PAGE (appropriate for ~70-100 kDa proteins like LecRKs)

  • Run at 100V through stacking, then 150V through resolving gel

• Transfer conditions:

  • Wet transfer recommended for large proteins

  • Use PVDF membrane (0.45 μm)

  • Transfer at 30V overnight at 4°C or 100V for 1 hour with cooling

• Blocking optimization:

  • 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Alternative: 3% BSA in TBST (especially if phospho-specific detection is important)

• Antibody incubation:

  • Primary antibody dilution: 1:1000 to 1:2000 in blocking buffer

  • Incubate overnight at 4°C with gentle rocking

  • Wash 5 × 5 minutes with TBST

  • Secondary antibody (anti-rabbit HRP) at 1:5000 for 1 hour at room temperature

  • Wash 5 × 5 minutes with TBST

• Detection strategy:

  • Enhanced chemiluminescence (ECL) substrate

  • Exposure time optimization: start with 30 seconds, then adjust

• Controls:

  • Positive control: LECRK3 overexpression sample

  • Negative control: tissue from LECRK3 knockout plants

  • Loading control: anti-tubulin or anti-actin antibodies

What are the considerations for immunoprecipitation experiments using LECRK3 antibodies?

When designing immunoprecipitation (IP) experiments with LECRK3 antibodies:

• Pre-clearing considerations:

  • Pre-clear lysate with 25 μl Protein A/G beads for 1 hour at 4°C

  • Remove non-specific binding proteins before antibody addition

• IP buffer optimization:

  • 50 mM Tris-HCl, pH 7.5

  • 150 mM NaCl

  • 0.5% NP-40 or 1% Triton X-100

  • 5 mM EDTA

  • 1 mM DTT

  • Protease and phosphatase inhibitors

  • Consider detergent type and concentration (critical for membrane proteins)

• Antibody binding conditions:

  • Use 2-5 μg antibody per 1 mg total protein

  • Incubate overnight at 4°C with gentle rotation

  • Add 30 μl Protein A/G beads, incubate 2-4 hours at 4°C

• Washing stringency balance:

  • 3-5 washes with IP buffer (containing detergent)

  • Final wash with low salt buffer (remove detergent)

  • More stringent washing reduces background but may reduce specific signal

• Elution methods:

  • Denaturing: 1× SDS sample buffer at 95°C for 5 minutes

  • Non-denaturing: Competitive elution with excess antigen peptide

• Controls needed:

  • IgG control (same species as primary antibody)

  • Input sample (5-10% of starting material)

  • IP from LECRK3 knockout material (if available)

• Co-IP considerations:

  • For studying LECRK3 interactions, crosslinking before lysis may stabilize transient interactions

  • Use spacer-arm cross-linkers like DSP (dithiobis(succinimidyl propionate))

  • Consider protein–protein interaction stabilization reagents

How can LECRK3 antibodies be used to study receptor-ligand interactions in plant immunity?

Using LECRK3 antibodies to study receptor-ligand interactions requires sophisticated approaches:

• Surface plasmon resonance (SPR) applications:

  • Immobilize purified LECRK3 on SPR chip using antibody-based capture

  • Flow potential ligands (e.g., pathogen-derived molecules) over chip

  • Measure binding kinetics (association/dissociation constants)

  • Compare binding parameters across different ligands

• Microscopy-based interaction studies:

  • Immunolabeling LECRK3 before/after pathogen challenge

  • Track receptor clustering or relocalization upon ligand exposure

  • Co-immunolabeling with fluorescently tagged potential ligands

  • Use FRET or BRET to detect direct interactions

• Pull-down strategy for ligand identification:

  • Crosslink receptor-ligand complexes in vivo after exposure

  • Immunoprecipitate LECRK3 using validated antibodies

  • Mass spectrometry analysis of co-precipitated molecules

  • Validation of identified interactions via reciprocal pull-downs

• Comparative analysis with other LecRKs:

  • Similar to how OsLecRK5 phosphorylates UGP1, LECRK3 may phosphorylate specific substrates

  • Use phospho-specific antibodies to detect substrate modification

  • Compare with other characterized LecRKs like OsLecRK1 that bind MLG-derived oligosaccharides

This approach can reveal whether LECRK3, like other characterized LecRKs, recognizes specific carbohydrate PAMPs or HAMPs (host-associated molecular patterns) through its lectin domain .

What technologies can integrate LECRK3 antibody data with transcriptomics and proteomics for comprehensive immune pathway analysis?

For multi-omic integration of LECRK3 studies:

• Antibody-based proteomics integration:

  • Use LECRK3 antibodies for Reverse Phase Protein Arrays (RPPA)

  • Correlate LECRK3 protein abundance with transcriptomic profiles

  • Identify post-transcriptional regulation mechanisms

  • Map timepoints where protein and mRNA levels diverge

• ChIP-seq applications:

  • Identify transcription factors regulating LECRK3 expression

  • Map temporal changes in chromatin state around LECRK3 locus

  • Correlate with expression data to build regulatory networks

• Spatial proteomics and transcriptomics integration:

  • Combine immunohistochemistry data with spatial transcriptomics

  • Build tissue-specific expression maps across development

  • Identify tissue-specific co-expression networks

• Pathway reconstruction and network analysis:

  • Use LECRK3 antibody data as anchor points in signaling networks

  • Similar to how OsLecRK1 links to jasmonate signaling in brown planthopper resistance

  • Map LECRK3 interactions within E3 ligase-regulated immune pathways

  • Compare with other characterized immune receptors

• Computational integration frameworks:

  • Bayesian network models integrating protein, RNA, and phenotypic data

  • Machine learning approaches to predict LECRK3 interaction partners

  • Network visualization tools to map LECRK3's position in immune signaling

This multi-omic approach can reveal LECRK3's potential role in the complex regulatory network connecting pattern recognition, hormone signaling, and defense responses in plants.

How can LECRK3 antibodies be used to study protein-protein interactions and signaling complexes in plant immune responses?

To investigate LECRK3's role in immune signaling complexes:

• Proximity-based interaction analysis:

  • BioID or TurboID fusion proteins with LECRK3

  • Antibody-based detection of biotinylated proximity partners

  • Confirmation with standard co-IP using LECRK3 antibodies

• Bimolecular Fluorescence Complementation (BiFC):

  • Confirm interactions identified by antibody-based methods

  • Similar to experiments used to study OsLecRK5 homodimerization

  • Use split fluorescent proteins fused to LECRK3 and candidate partners

  • Verify with LECRK3 antibodies in parallel experiments

• Blue Native PAGE for complex integrity:

  • Preserve native protein complexes containing LECRK3

  • Western blot with LECRK3 antibodies after native separation

  • Identify complex components via mass spectrometry

  • Map complex assembly/disassembly during immune responses

• Signaling dynamics study:

  • Use phospho-specific antibodies to track LECRK3 activation

  • Monitor phosphorylation of downstream substrates

  • Track temporal dynamics during immune response

  • Compare with kinase assays using immunoprecipitated LECRK3

• Super-resolution microscopy applications:

  • Immunolocalization of LECRK3 using validated antibodies

  • Co-localization with other immune receptors

  • Track receptor clustering during immune activation

  • Measure spatial reorganization during signaling

These approaches can help determine whether LECRK3 forms heterodimers like other LecRKs or interacts with components of known immune signaling pathways like those involving E3 ligases .

What are the considerations for developing and validating phospho-specific antibodies for LECRK3?

Developing phospho-specific antibodies for LECRK3 requires:

• Phosphorylation site identification:

  • Conduct phosphoproteomics on LECRK3 after immune stimulation

  • Map functionally important phosphorylation sites

  • Focus on conserved motifs in the kinase domain

  • Consider the ATP-binding lysine residue (similar to K418 in OsLecRK5)

• Phosphopeptide design considerations:

  • Synthesize peptides containing identified phosphorylation sites

  • Include 10-15 amino acids surrounding the phosphosite

  • Ensure peptide is soluble and immunogenic

  • Prepare both phosphorylated and non-phosphorylated versions

• Antibody production strategy:

  • Immunize rabbits with phosphopeptide conjugated to carrier protein

  • Perform sequential affinity purification:

    • First against non-phosphorylated peptide (negative selection)

    • Then against phosphorylated peptide (positive selection)

• Validation requirements:

  • Western blot with samples containing phosphorylated/non-phosphorylated LECRK3

  • Test with phosphatase-treated samples (signal should disappear)

  • Verify with kinase-dead LECRK3 mutants

  • Peptide competition assays with phospho and non-phospho peptides

• Controls for experimental use:

  • Use kinase inhibitors to generate negative control samples

  • Include samples from immune-stimulated tissues (positive controls)

  • Check cross-reactivity with other phosphorylated LecRKs

This approach follows established protocols for generating phospho-specific antibodies against receptor kinases and can help track LECRK3 activation during immune responses.

What are common sources of experimental variability when using LECRK3 antibodies and how can they be addressed?

Common sources of variability and their solutions include:

• Antibody batch variation:

  • Problem: Different lots may have different specificities/sensitivities

  • Solution: Validate each new lot against a reference standard

  • Implementation: Maintain reference samples and standard curves

• Sample preparation inconsistencies:

  • Problem: Variable extraction efficiency, protein degradation

  • Solution: Standardize harvesting, extraction, and storage procedures

  • Implementation: Use consistent buffer:tissue ratios, processing times

• Expression level differences:

  • Problem: LECRK3 expression varies by tissue, developmental stage, and environmental conditions

  • Solution: Use time-course experiments with appropriate controls

  • Implementation: Include stage-matched controls, normalize to consistent reference genes/proteins

• Cross-reactivity issues:

  • Problem: Antibodies may detect related LecRK family members

  • Solution: Validate with knockout/knockdown controls

  • Implementation: Include specificity controls in each experiment

• Post-translational modification state:

  • Problem: Phosphorylation may affect antibody binding

  • Solution: Use phosphatase treatment controls

  • Implementation: Split samples and treat half with λ-phosphatase

• Technical variation in immunoblotting:

  • Problem: Inconsistent transfer efficiency, blocking, antibody binding

  • Solution: Use standardized protocols and internal loading controls

  • Implementation: Include gradient standards on each blot

Addressing these variables is critical as the quality and reproducibility of antibody-based experiments remain a challenge in the research community .

How can researchers address non-specific binding issues when using LECRK3 antibodies?

To minimize non-specific binding:

• Optimized blocking strategies:

  • Test different blocking agents (BSA, milk, commercial blockers)

  • Extend blocking time (2-3 hours at room temperature)

  • Add 0.1-0.5% Tween-20 to blocking solution

  • Consider using protein-free blockers if background persists

• Antibody dilution optimization:

  • Perform titration series (1:500 to 1:5000)

  • Use antibody dilution buffer with 0.05% Tween-20

  • Add 1-5% of blocking agent to antibody solution

  • Consider overnight incubation at 4°C at higher dilutions

• Stringent washing protocols:

  • Increase wash buffer volume (10-15 ml per wash)

  • Extend wash times (5-6 washes of 10 minutes each)

  • Add salt to wash buffer (up to 500 mM NaCl)

  • Consider detergent concentration adjustments

• Pre-adsorption techniques:

  • Pre-incubate antibody with proteins from non-target species

  • Use acetone powder from non-target tissue

  • Consider protein A/G pre-clearing of samples

• Epitope competition controls:

  • Pre-incubate antibody with immunizing peptide

  • Should eliminate specific signal while leaving non-specific intact

  • Helps distinguish true signal from background

These approaches are particularly important since non-specific binding is one of the major issues affecting antibody reliability in research .

What controls are essential when evaluating LECRK3 expression patterns across different tissues or under various stress conditions?

Essential controls for comparative LECRK3 expression studies:

• Genetic controls:

  • LECRK3 knockout/knockdown lines as negative controls

  • LECRK3 overexpression lines as positive controls

  • Empty vector transformants as baseline controls

• Technical validation controls:

  • Loading controls (anti-actin, anti-tubulin, anti-GAPDH)

  • Total protein staining (Ponceau S, Coomassie, SYPRO Ruby)

  • Recombinant LECRK3 protein standards at known concentrations

• Biological reference controls:

  • Samples from tissues known to express LECRK3

  • Developmental stage series to normalize for age effects

  • Well-characterized stress responses (e.g., chitin treatment)

• Method validation controls:

  • RNA expression correlation (RT-qPCR of LECRK3 transcripts)

  • Independent antibody verification (second antibody against different epitope)

  • In situ protein localization (immunohistochemistry)

• Environmental standardization:

  • Controlled growth conditions for all compared samples

  • Time-of-day standardization (for diurnal cycle effects)

  • Consistent stress application protocols

Implementing these controls is essential for reproducible research, as studies have shown that antibody performance can vary significantly across different experimental contexts .

How can researchers interpret contradictory results between LECRK3 transcript levels and protein abundance detected by antibodies?

When facing discrepancies between transcript and protein data:

• Potential biological explanations:

  • Post-transcriptional regulation (miRNA targeting LECRK3 mRNA)

  • Differential protein stability under stress conditions

  • Subcellular relocalization affecting extraction efficiency

  • Post-translational modifications altering antibody recognition

• Methodological verification approaches:

  • Use multiple antibodies targeting different LECRK3 epitopes

  • Perform polysome profiling to assess translation efficiency

  • Measure protein half-life using cycloheximide chase

  • Assess ubiquitination status (potential degradation)

• Integrative analysis strategies:

  • Plot time-course data showing transcript vs. protein levels

  • Calculate time lags between mRNA and protein changes

  • Test for correlations with known regulators (e.g., E3 ligases)

• Technical validation:

  • Verify RNA-seq/qPCR with spike-in controls

  • Confirm antibody specificity in the specific experimental context

  • Assess protein extraction efficiency across sample types

• Data integration framework:

  Analysis Level	Technique	Information Provided
  Transcription	RNA-seq/qPCR	LECRK3 mRNA levels
  Translation	Polysome profiling	Translation efficiency
  Protein abundance	Western blot	Total LECRK3 protein
  Protein localization	Cell fractionation + WB	Compartmentalization
  Protein modification	IP + MS analysis	PTM landscape
  Protein turnover	CHX chase	Stability/degradation

This integrated approach can help distinguish biological regulation from technical artifacts when transcript and protein data don't align.

How might CRISPR-engineered knockin tags improve upon traditional LECRK3 antibody applications?

CRISPR-based tagging offers several advantages over traditional antibodies:

• Endogenous tagging benefits:

  • Expression at physiological levels (avoids overexpression artifacts)

  • Maintains native regulation and tissue-specific expression patterns

  • Preserves authentic protein-protein interactions

  • Enables live-cell imaging without fixation artifacts

• Tag options and considerations:

  • Small epitope tags (FLAG, HA, V5) - minimal disruption but require antibodies

  • Fluorescent protein fusions (GFP, mCherry) - direct visualization but larger

  • Split tag complementation systems - for interaction studies

  • SNAP/CLIP/Halo tags - for pulse-chase and super-resolution imaging

• Strategic tag placement:

  • C-terminal tags - generally less disruptive for LecRKs

  • Internal tags - require careful domain boundary analysis

  • Multiple tags - enables different applications with same line

• Validation requirements:

  • Confirm tag doesn't disrupt LECRK3 function

  • Verify expression patterns match endogenous protein

  • Test immune response phenotypes for equivalence

• Advanced applications:

  • Combine with tissue-specific promoters for cell-type specific analysis

  • Integrate with optogenetic modules for controlled activation

  • Pair with proximity labeling for in vivo interactome studies

This approach addresses the fundamental antibody reproducibility crisis while providing new tools to study LECRK3 function in plant immunity .

What emerging single-cell and spatial techniques could be combined with LECRK3 antibodies for advanced immune response mapping?

Cutting-edge methods for spatial and single-cell LECRK3 analysis:

• Single-cell protein analysis approaches:

  • Mass cytometry (CyTOF) with LECRK3 antibodies

  • Microfluidic single-cell Western blotting

  • Single-cell proteomics with antibody-based enrichment

  • Application: Identify rare cell populations with high LECRK3 activity

• Spatial proteomics techniques:

  • Imaging mass cytometry with LECRK3 antibodies

  • Multiplexed ion beam imaging (MIBI)

  • Co-detection by indexing (CODEX)

  • Application: Map LECRK3 distribution at infection sites

• In situ interaction mapping:

  • Proximity ligation assay (PLA) for LECRK3 interaction partners

  • Spatially resolved protein-protein interaction mapping

  • Combined with RNAscope for simultaneous transcript detection

  • Application: Correlate LECRK3 activation with transcriptional changes

• Tissue-specific immune response profiling:

  • Laser capture microdissection + antibody-based proteomics

  • Spatial transcriptomics with protein validation

  • Digital spatial profiling with LECRK3 antibodies

  • Application: Map infection response zones in plant tissues

• Live imaging approaches:

  • Antibody fragments for live plant cell imaging

  • Nanobody-based sensors for LECRK3 activation state

  • Integration with microfluidic pathogen delivery systems

  • Application: Real-time visualization of immune receptor activation

These technologies could transform our understanding of plant immune receptor dynamics during pathogen attack, similar to advances made in mammalian immunology.

How might monoclonal antibody development technologies be applied to create more specific LECRK3 detection reagents?

Advanced monoclonal antibody technologies for improved LECRK3 reagents:

• Recombinant antibody advantages:

  • Sequence-defined reagents with permanent availability

  • Elimination of animal immunization variability

  • Potential for engineering enhanced properties

  • Application: Creating renewable LECRK3 detection reagents

• Phage display selection strategies:

  • Negative selection against related LecRK family members

  • Selection under different buffer conditions

  • Counter-selection against denatured antigen for conformation-specific binders

  • Application: Generating antibodies with defined specificity profiles

• Antibody engineering approaches:

  • Affinity maturation through directed evolution

  • Format switching (IgG, Fab, scFv, nanobody)

  • Fusion to detection enzymes or fluorescent proteins

  • Application: Creating application-optimized LECRK3 detection tools

• Humanized antibody frameworks:

  • Reduced background in plant tissue (less cross-reactivity)

  • Improved stability and reduced aggregation

  • Compatibility with human Fc detection reagents

  • Application: Cleaner detection in complex plant extracts

• Site-specific modification:

  • Controlled conjugation chemistry for labeling

  • Oriented immobilization for biosensor development

  • Application: Development of LECRK3 quantification tools

This approach follows the recommendations from the antibody reproducibility initiative, focusing on creating defined, renewable reagents rather than relying on traditional polyclonal antibodies .

How can computational modeling inform antibody development and application for studying the LECRK3 immune signaling network?

Computational approaches for LECRK3 antibody research:

• Epitope prediction and accessibility modeling:

  • 3D structure prediction of LECRK3 using AlphaFold

  • Identification of surface-exposed, unique regions

  • Conformational epitope analysis

  • Application: Targeting antibody development to accessible, specific regions

• Cross-reactivity prediction:

  • Sequence and structural alignment with related LecRKs

  • Identification of unique vs. conserved epitopes

  • Homology modeling of antibody-antigen complexes

  • Application: Designing highly specific antibodies

• Network modeling for assay design:

  • Predict key interaction partners based on other LecRK networks

  • Model signaling cascades to identify optimal detection timepoints

  • Simulate network perturbations to predict antibody utility

  • Application: Designing time-resolved experiments to capture LECRK3 dynamics

• Machine learning for antibody performance prediction:

  • Train models on existing antibody validation data

  • Predict optimal applications for each antibody

  • Identify potential cross-reactivity issues

  • Application: Prioritizing antibody candidates before synthesis

• Molecular dynamics simulations:

  • Model antibody-antigen binding dynamics

  • Predict effects of buffer conditions on recognition

  • Simulate effects of post-translational modifications

  • Application: Optimizing experimental conditions for detection